CELU
Price:
$1.55
Market Cap:
$34.08M
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic ...[Read more]
Industry
Biotechnology
IPO Date
2019-08-08
Stock Exchange
NASDAQ
Ticker
CELU
According to Celularity Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 71.97M. This represents a change of -44.20% compared to the average of 128.99M of the last 4 quarters.
The mean historical Enterprise Value of Celularity Inc. over the last ten years is 249.56M. The current 71.97M Enterprise Value has changed 2.78% with respect to the historical average. Over the past ten years (40 quarters), CELU's Enterprise Value was at its highest in in the June 2021 quarter at 1.25B. The Enterprise Value was at its lowest in in the September 2023 quarter at 102.49M.
Average
249.56M
Median
259.86M
Minimum
109.19M
Maximum
352.31M
Discovering the peaks and valleys of Celularity Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 88.47%
Maximum Annual Enterprise Value = 352.31M
Minimum Annual Increase = -57.19%
Minimum Annual Enterprise Value = 109.19M
Year | Enterprise Value | Change |
---|---|---|
2023 | 109.19M | -57.19% |
2022 | 255.04M | -24.37% |
2021 | 337.23M | 88.47% |
2020 | 178.93M | -32.40% |
2019 | 264.68M | -24.87% |
The current Enterprise Value of Celularity Inc. (CELU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
233.82M
5-year avg
229.01M
10-year avg
249.56M
Celularity Inc.’s Enterprise Value is greater than Immix Biopharma, Inc. (20.49M), greater than ZyVersa Therapeutics, Inc. (1.84M), greater than Hepion Pharmaceuticals, Inc. (1.72M), greater than AVROBIO, Inc. (-85302404.00), greater than eFFECTOR Therapeutics, Inc. (3.64M), greater than CNS Pharmaceuticals, Inc. (2.61M), less than VectivBio Holding AG (848.58M), less than Navidea Biopharmaceuticals, Inc. (0), greater than Sonnet BioTherapeutics Holdings, Inc. (-2555017.00), greater than null (-448232.00),
Company | Enterprise Value | Market cap |
---|---|---|
20.49M | $43.37M | |
1.84M | $1.96M | |
1.72M | $3.68M | |
-85302404.00 | $5.24M | |
3.64M | $1.88K | |
2.61M | $3.98M | |
848.58M | $1.06B | |
0 | $50.04K | |
-2555017.00 | $2.96M | |
-448232.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celularity Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celularity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Celularity Inc.'s Enterprise Value?
What is the highest Enterprise Value for Celularity Inc. (CELU)?
What is the 3-year average Enterprise Value for Celularity Inc. (CELU)?
What is the 5-year average Enterprise Value for Celularity Inc. (CELU)?
How does the current Enterprise Value for Celularity Inc. (CELU) compare to its historical average?